Orgenesis (ORGS) Stock Statistics & Valuation Metrics

Orgenesis has a market cap or net worth of $315.32K. The enterprise value is $37.17M.

Orgenesis has 5,169,248 shares outstanding. The number of shares has decreased by -2.65% in one year.

Orgenesis’s return on equity (ROE) is 2.64 and return on invested capital (ROIC) is -3180.09%.

The current PE Ratio of Orgenesis is ―. Orgenesis’s PEG ratio is ―.

In the last 12 months, Orgenesis had revenue of 530.00K and earned -55.36M in profits. Earnings per share was -1.91.

In the last 12 months, operating cash flow was -14.98M and capital expenditures -263.00K, giving a free cash flow of -15.24M billion.

Orgenesis pays an annual dividend of ―, resulting in a dividend yield of ―

Orgenesis upcoming earnings date is Aug 19, 2025, TBA (Confirmed).

Orgenesis as a current ratio of 0.25, with Debt / Equity ratio of -72.38%

In the past 12 months, Orgenesis has paid 473.00K in taxes.

Orgenesis EV to EBITDA ratio is -2.75, with an EV/FCF ratio of -9.85.

Orgenesis has $204.00K in cash and marketable securities with $17.30M in debt, giving a net cash position of -$17.09M billion.

Gross margin is -156.27%, with operating margin of -10120.00%, and net profit margin of -10445.47%.

The average price target for Orgenesis is ―, which is 11.43% higher than the current price. The consensus rating is ―